Is Xenon Pharmaceuticals Inc. (XENE) a Buy, Sell, or Hold?
NASDAQ : XENE
Xenon Pharmaceuticals Inc. — Analyst Ratings
$64.94 USD
-$0.84 (-1.28%)
- Volume
- 472.55K
- Average Volume
- 1.44M
- Market Capitalization
- $6.28B
- P/E Ratio
- -13.82
- Dividend Yield
- 0.00%
- Price Target
- $89.50
- Year High
- $72.66
- Year Low
- $30.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.79
Analyst Consensus Summary
Consensus Rating
Sell
22 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-27.4%
vs Current Price
Price Target
$89.50
Average TargetPrice Target Range
Lowest Target
$60.00
8.2% UPSIDE
Average Target
$89.50
Median Estimate
Highest Target
$100.00
-35.1% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 22
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 22 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wells Fargo | Benjamin Burnett | $69 | $56.44 | 2026-05-10 10:17 AM | 22.3% |
| Needham | Serge Belanger | $78 | $56.545 | 2026-05-08 09:46 AM | 37.9% |
| Jefferies | Andrew Tsai | $100 | $62.76 | 2026-03-09 03:52 PM | 59.3% |
| Guggenheim | Yatin Suneja | $90 | $62.76 | 2026-03-09 02:47 PM | 43.4% |
| Stifel Nicolaus | Paul Matteis | $89 | $61.58 | 2026-03-09 09:30 AM | 44.5% |
| Jefferies | Andrew Tsai | $65 | $61.56 | 2026-03-09 09:18 AM | 5.6% |